Abstracts:
Pamidronate, a bisphosphonate analogue has been evaluated in a retrospective study for its analgesic effect on chronic back pain due to vertebral fractures in 26 patients suffering from senile osteoporosis or glucocorticoid-induced osteoporosis. Sixty milligrams of pamidronate was administered intravenously every 3 months for one year. After three months of treatment, the pain score fell from 3.2 ± 0.1 to 1.2 ± 0.2 in both groups. In conclusion, intravenous pamidronate seems to be a valuable treatment for chronic back pain due to osteoporotic vertebral fractures.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 17 July 1998 / Accepted: 18 December 1998
Rights and permissions
About this article
Cite this article
Gangji, V., Appelboom, T. Analgesic Effect of Intravenous Pamidronate on Chronic Back Pain due to Osteoporotic Vertebral Fractures. Clin Rheumatol 18, 266–267 (1999). https://doi.org/10.1007/s100670050099
Issue Date:
DOI: https://doi.org/10.1007/s100670050099